Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	8.29	7.11	7.83	8.54	3.19	1.13
Cash & Short-Term Investments	8.29	7.11	7.83	8.54	3.19	1.13
Cash Growth	42.59%	-9.27%	-8.24%	167.33%	182.11%	-50.31%
Receivables	18.45	19.45	3.09	3.06	3.5	4.11
Inventory	20.16	12.93	9.55	6.74	5.01	4.14
Prepaid Expenses	1.14	0.52	1.03	0.53	0.49	0.87
Total Current Assets	48.05	40.01	21.51	18.86	12.19	10.25
Property, Plant & Equipment	13.87	14.61	10.44	6.98	6.86	7.59
Other Intangible Assets	0.29	0.29	0.29	0.47	0.47	0.47
Long-Term Deferred Tax Assets	20.69	22.16	2.17	2.17	-	-
Long-Term Deferred Charges	6.95	6.05	6.05	6.17	6.17	6.17
Other Long-Term Assets	0.91	0.53	0.43	0.5	0.5	0.48
Total Assets	90.76	83.65	40.9	35.15	26.19	24.96
Accounts Payable	5.84	2.71	2.45	1.43	0.93	1.58
Accrued Expenses	3.11	4.82	4.63	4.28	4.27	4.82
Short-Term Debt	4.1	4	-	-	-	-
Current Portion of Long-Term Debt	0.29	0.3	0.31	0.35	0.41	1.85
Current Portion of Leases	0.83	0.72	0.01	0.2	0.19	0.21
Current Income Taxes Payable	0.51	0.49	0.41	0.41	-	-
Current Unearned Revenue	0.01	0.01	0.01	0.01	0.01	0.18
Total Current Liabilities	14.69	13.05	7.83	6.69	5.81	8.64
Long-Term Debt	3.05	3.28	3.56	1.39	1.74	1.8
Long-Term Leases	3	3.44	-	0.84	0.04	0.17
Long-Term Unearned Revenue	-	0.01	0.02	0.03	0.05	0.06
Other Long-Term Liabilities	33.57	6.3	0.52	0.98	2.4	3.63
Total Liabilities	54.31	26.07	11.94	9.93	10.04	14.3
Common Stock	1.07	1.07	1.01	1.01	1.01	0.84
Additional Paid-In Capital	173.39	173.21	164.75	164.58	164.41	150.26
Retained Earnings	-137.7	-116.39	-136.5	-140.06	-148.96	-154.05
Treasury Stock	-0.31	-0.31	-0.31	-0.31	-0.31	-0.31
Total Common Equity	36.45	57.58	28.96	25.22	16.15	-3.25
Shareholders' Equity	36.45	57.58	28.96	25.22	16.15	10.66
Total Liabilities & Equity	90.76	83.65	40.9	35.15	26.19	24.96
Total Debt	11.28	11.74	3.89	2.78	2.38	4.03
Net Cash (Debt)	-2.98	-4.63	3.94	5.75	0.81	-2.9
Net Cash Growth	-	-	-31.44%	606.63%	-	-
Net Cash Per Share	-0.00	-0.00	0.00	0.01	0.00	-0.00
Filing Date Shares Outstanding	1,068	1,068	1,014	1,011	1,009	840.4
Total Common Shares Outstanding	1,068	1,068	1,014	1,011	1,009	840.4
Working Capital	33.36	26.96	13.68	12.17	6.38	1.61
Book Value Per Share	0.03	0.05	0.03	0.02	0.02	-0.00
Tangible Book Value	36.16	57.29	28.67	24.76	15.69	-3.71
Tangible Book Value Per Share	0.03	0.05	0.03	0.02	0.02	-0.00
Land	11.65	11.06	10.77	5.46	5.46	5.26
Machinery	14.95	15.02	14.24	13.85	13.35	12.92

Source: S&P Capital IQ. Standard template. Financial Sources.